Literature DB >> 28424224

Novel Strategies to Reduce Femoropopliteal Restenosis: Low-Dose Paclitaxel-Coated Balloons and Paclitaxel-Coated Balloons Plus Stenting.

Andrew M Goldsweig1, Herbert D Aronow2.   

Abstract

Entities:  

Keywords:  Editorials; balloon angioplasty; femoral artery; paclitaxel; peripheral arterial disease; stents

Mesh：

Substances：

Year:  2017        PMID： 28424224     DOI： 10.1161/CIRCULATIONAHA.117.028308

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  1 in total

1.  Highly Selective PPARα (Peroxisome Proliferator-Activated Receptor α) Agonist Pemafibrate Inhibits Stent Inflammation and Restenosis Assessed by Multimodality Molecular-Microstructural Imaging.

Authors:  Hiroshi Iwata; Eric A Osborn; Giovanni J Ughi; Kentaro Murakami; Claudia Goettsch; Joshua D Hutcheson; Adam Mauskapf; Peter C Mattson; Peter Libby; Sasha A Singh; Joan Matamalas; Elena Aikawa; Guillermo J Tearney; Masanori Aikawa; Farouc A Jaffer
Journal:  J Am Heart Assoc       Date:  2021-10-11       Impact factor: 5.501
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.